How to Microdose GLP-1: Compounded Products, Explained

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight-management options, and the genetic variables behind every metabolic decision.

A "microdose" GLP-1 is one variety of compounded formulation — a preparation of the active ingredient made by a licensed 503A compounding pharmacy, distinct from an FDA-approved brand. To understand where microdosing fits, it helps to see the whole compounding picture: what these pharmacies may legally do, what the 2024–2025 shortage resolutions changed, how compounded products stack up against brands, and where variations like semaglutide-plus-B12 and lower-dose formulas come in.

What a 503A pharmacy is allowed to make

503A pharmacies are state-licensed compounders that fill patient-specific prescriptions under a valid prescriber order. Federal law lets them compound in three broad situations: when a product is not commercially available, when it appears on the FDA drug shortage list, and when a patient-specific formulation — a different strength, combination, or vehicle — is medically necessary for an individual. State pharmacy boards and the FDA share oversight of this activity.

How the 2024–2025 shortage resolutions reshaped things

The FDA declared both semaglutide and tirzepatide in shortage in 2022, and during those declarations 503A pharmacies could compound the molecules under the shortage pathway. The agency resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed — without closing — the legitimate compounding window. Compounded semaglutide and tirzepatide remain available through the not-commercially-available and patient-specific pathways where clinically justified.

Compounded versus brand: the real differences

Compounded products are legally and factually different from FDA-approved brands. They do not go through the same FDA manufacturing review, they run on pharmacy-specific quality processes, and they may use different vehicles, strengths, or combinations. Quality varies by pharmacy, so verify state licensure and, when you can, third-party testing. In no regulatory sense are compounded products "generics."

Common compounded variations, including microdose

Two variations show up often.

Semaglutide with B12

Semaglutide combined with cyanocobalamin (vitamin B12) is a frequent formulation. The B12 can reduce injection-site irritation for some people and may support energy and neurological health in those who are B12-deficient. It is a patient-specific choice made by the prescriber, not a universal addition to every preparation.

Microdose formulations

"Microdose" formulas deliver lower doses than standard titration schedules, sometimes for people who experience significant GI side effects at label-directed doses. The specific strength combinations are patient-specific per the prescriber order. PlexusDx offers a Microdose GLP-1 Protocol among its Weight Management Protocols.

Safety checkpoints

Confirm the compounding pharmacy is licensed in your state, and make sure the prescriber runs a clinical evaluation and reviews contraindications. Be wary of vendors that ship without prescriptions, take only cryptocurrency, or market "research chemical" products. Legitimate compounded products carry patient-specific labeling, lot numbers, beyond-use dates, and storage instructions consistent with USP <797> (nonsterile) or USP <797>/<800> (sterile) standards.

The genetic context beneath compounded GLP-1

What distinguishes the PlexusDx approach is the upstream biology. Before any GLP-1 protocol, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights — including variants in FTO, GLP1R, MC4R, and TCF7L2 that shape baseline GLP-1 and energy-balance biology. It never predicts response to a compounded or brand product; it simply adds trait context for the conversation with your provider. That is the test-before-you-invest idea in practice.

Who considers a lower-dose approach

Microdose formulations are often discussed for people who experience significant GI side effects at label-directed doses, since a lower exposure can be a gentler starting point. Because these are patient-specific preparations, the exact strength is set by the prescriber for the individual rather than pulled from a standard schedule. That makes a genuine clinical evaluation essential: the provider decides whether a lower-dose formulation fits, and a licensed 503A pharmacy prepares it under that order. It is worth confirming the pharmacy's state licensure and asking how the preparation is labeled and dated. A microdose is not a shortcut around clinical oversight; it is one more patient-specific option within a regulated compounding pathway, and it works best when the evaluation behind it is thorough.

Frequently Asked Questions

What exactly is a microdose GLP-1?

A microdose GLP-1 is a compounded formulation delivering a lower dose than standard titration schedules, prepared by a licensed 503A pharmacy under a valid prescriber order. It is legally and factually different from an FDA-approved brand, and its strength is patient-specific. Verify state licensure and a genuine clinical evaluation before using one.

Is compounded GLP-1 the same as the brand?

No. Compounded products are not subject to the same FDA manufacturing review as brands and may differ in strength, vehicle, combinations, and quality controls. They are not generics, and quality varies by pharmacy. PlexusDx Weight Management Protocols work through licensed compounding pathways and publish per-protocol pricing on each product page.

Why do some formulas add B12?

Cyanocobalamin (vitamin B12) is sometimes added to compounded GLP-1 formulations because it can ease injection-site discomfort for some people and may help those who are B12-deficient. It is a patient-specific decision made by the prescribing provider based on the individual, not a standard ingredient in every compounded preparation.

Does the genetic test predict how a microdose will work?

No. The Precision Peptide Genetic Test does not predict response to compounded semaglutide, tirzepatide, or any formulation. It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that relate to baseline GLP-1 and energy-balance biology — upstream context that applies to every GLP-1 protocol rather than a forecast of any single dose.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.